Shares of Verastem Inc , Huntsman Corporation , and TrovaGene Inc are among the top losers today as the firms’ share prices have declined by 65%, 24%, and 8%, respectively. Verastem shares dropped on the back of news that the Phase 2 study of its VS-6063 drug was stopped.
